The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: First results of the Berlin Multi-Centre FST validation study

Multiple Sclerosis

Volumn 13, Issue 3, 2007, Pages 402-411

  Scherer, Peter ^a   Penner, I K ^b   Rohr, A ^b   Boldt, H ^c   Ringel, I ^c   Wilke Burger, H ^c   Burger Deinerth, E ^c   Isakowitsch, K ^c   Zimmermann, M ^c   Zahrnt, S ^a   Hauser, R ^c   Hilbert, K ^c   Tiel Wilck, K ^c   Anvari, K ^c   Behringer, A ^c   Peglau, I ^c   Friedrich, H ^c   Plenio, A ^c   Benesch, G ^a   Ehret, R ^c   Nippert, I ^c   Finke, G ^c   Schulz, I ^d   Bergtholdt, B ^d   Breitkopf, S ^e   Kaskel, P ^e   Reischies, F ^f   Kugler, J ^g   more..

^a University of Basel ^*  (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Berlin MS Working Group   (Germany)

^d Emovis GmbH   (Germany)

^e BAYER PHARMA AG   (Germany)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cognitive impairment; Faces Symbol Test; Multiple sclerosis; Neuropsychology; PASAT; Screening test

Indexed keywords

BETA INTERFERON; GLATIRAMER; IMMUNOMODULATING AGENT;

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EXPANDED DISABILITY STATUS SCALE; FACES SYMBOL TEST; FEMALE; GERMANY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHYSICAL DISEASE; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYMBOLISM; VALIDATION STUDY;

ATTENTION; BERLIN; COGNITION; COGNITION DISORDERS; EMOTIONS; FACE; HUMANS; MEMORY; MULTIPLE SCLEROSIS; PILOT PROJECTS; PSYCHOLOGICAL TESTS; QUESTIONNAIRES; RECOGNITION (PSYCHOLOGY); REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THINKING;

EID: 34248155189     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506069674     Document Type: Article

References (48)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-91.
2. Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 443-46.
3. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis. A reappraisal after 10 years. Arch Neurol 2001; 58: 1602-606.
4. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning. Neurology 1991; 41: 692-96.
5. Benedict RHB, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behaviour change. J Neurol Sci 2005; 231: 29-34.
6. Benedict RHB, Munschauer F, Linn R, Miller C, Murphy E, Foley F et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003; 9: 95-101.
7. Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch Neurol 1990; 47: 297-301.
8. Swirsky-Sacchetti T, Field HL, Mitchell DR, Seward J, Lublin FD, Knobler RL et al. The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis. J Clin Psychol 1992; 48: 779-86.
9. Beatty WW, Paul RH, Wilhanks SL, Hames KA, Blanco CR, Goodkin DE. Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). Neurology 1995; 45: 718-23.
10. Basso MR, Beason-Hazen S, Lynn J, Rammohan K, Bornstein RA. Screening for cognitive dysfunction in multiple sclerosis. Arch Neurol 1996; 53: 980-84.
11. Rao SM and the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. Medical College of Wisconsin, 1990.
12. Bever CT Jr, Grattan L, Panitch HS, Johnson KP. The Brief Repeatable Battery of Neuropsychological Tests for multiple sclerosis: a preliminary serial study. Mult Scler 1995; 1: 165-69.
13. Boringa JB, Lazeron RHC, Reuling IEW, Ader HJ, Pfennings L, Lindeboom J et al. The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001; 7: 263-67.
14. Scherer P, Baum K, Bauer H, Göhler H, Miltenburger C. Normierung der Brief Repeatable Battery of Neuropsychological Tests (BRB-N) für den deutschsprachigen Raum und Anwendung bei schubförmig remittierenden und sekundär progredienten Multiple-Sklerose-Patienten. Nervenarzt 2004; 75: 984-90.
15. Gronwall D. Paced Auditory Serial Addition Task: a measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-73.
16. Smith A. Symbol Digit Modalities Test. Western Psychological Services, 1991.
17. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-50.
18. Benedict RHB, Cox D, Thompson LL, Foley F, Weinstock-Guttman B, Munschauer F. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 2004; 10: 675-78.
19. Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/ progressive multiple sclerosis. Neurology 1988; 38: 1826-29.
20. Smith A, Pondsford J, Kinsella G. Attentional deficits following closed head injury. J Clin Exp Neuropsychol 1992; 14: 822-38.
21. Wechsler D. Wechsler Adult Intelligence Scale - revised: manual. Psychological Corporation, 1981.
22. Lezak MD. Neuropsychological assessment, third edition. Oxford University Press, 1995: 379-80.
23. Scherer P, Rohr A, Wilke-Burger H, Burger-Deinerth E, Boldt H, Anvari K et al. The Faces Symbol Test: a newly developed sensitive neuropsychological screening instrument for cognitive decline related to multiple sclerosis - first results of the Berlin Multi-Centre FST validation study. Mult Scler 2003; 9: S24.
24. Scherer P, Zahrnt S, Ringel I. Der Faces-Symbol-Test (EST) als Screeninginstrument zur Erfassung kognitiver Störungen bei Multipler Sklerose (MS). Aktuelle Neurol 2003; 30: S116.
25. Breitkopf S, Scherer P, Kaskel P, Schilli MB. The Faces Symbol Test allows a reliable cognitive screening in multiple sclerosis. Mult Scler 2005; 11: S71.
26. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-27.
27. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
28. Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Administration and scoring manual for the Multiple Sclerosis Functional Composite measure (MSFC). National Multiple Sclerosis Society, 2001.
29. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
30. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-89.
31. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-23.
32. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45: 1956-61.
33. Scherer P, Pohle S, Polzer U, Ringel I. Kognitive Störungen, Depression und Fatigue bei MS. Aktuelle Neurologie 2002; 2: S158.
34. Wechsler D. Handanweisung zum Hamburg-Wechsler-Intelligenztest für Erwachsene (HA WIE). Huber, 1982.
35. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45.
36. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
37. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
38. Centor RM. The use of ROC curves and their analyses. Med Dec Making 1991; 11: 102-43.
39. Kaskel P, Berking C, Sander S, Volkenandt M, Peter RU, Krähn G. S-100 protein in peripheral blood: a marker for melanoma metastases. J Am Acad Dermatol 1999; 41: 962-69.
40. Swets JA. The relative operating characteristic in psychology. Science 1973; 182: 990-1000.
41. Wilson RS, Rosenbaum G, Brown G. The problem of premorbid intelligence in neuropsychological assessment. J Clin Neuropsychol 1979; 1: 49-53.
42. Benedict RHB. Integrating cognitive function screening and assessment. CNS Spectr 2005; 10: 384-91.
43. Aupperle RL, Beatty WW, Shelton FdeN, Goutkowsky ST. Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler 2002; 8: 382-89.
44. Fisk JD, Archibald CJ. Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis. J Int Neuropsychol Soc 2001; 7: 363-72.
45. Lezak MD. Neuropsychological assessment, third edition. Oxford University Press, 1995: 372-78.
46. Fischer JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM et al. Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis. Ann Neurol 2000; 48: 885-92.
47. Marrie RA, Miller DM, Chelune GJ, Cohen JA. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler 2003; 9: 621-26.
48. Scherer P, Rohr A. Corticoid effects on working memory in multiple sclerosis patients with acute relapses. Mult Scler 2004; 10: S122-23.